Business Insider

Ortho Clinical Diagnostics' Quantitative COVID-19 IgG Antibody Test First to Receive FDA Emergency Use Authorization

- Ortho's new VITROS ® Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which gives clinicians ...
Newswire

Ortho Launches Second COVID-19 Antibody Test With 100% Specificity

- Ortho receives FDA Emergency Use Authorization for its second COVID-19 antibody test - Similar to Ortho's total COVID-19 antibody test, Ortho's IgG test demonstrated 100% specificity and can be used ...
Business Insider

Ortho's VITROS® SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data

RARITAN, N.J., March 23, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it received authorization ...
Finanznachrichten

Ortho's COVID-19 IgG Antibody Test Receives CE Mark

- Ortho's IgG test demonstrates 100% specificity and can be used to support decisions for getting people back to work and can support convalescent plasma screening - Ortho's Total antibody test ...
The Trentonian

Ortho’s VITROS(R) SARS-CoV-2 Antigen Test for High-Volume COVID-19 Testing Receives CE Mark; Allows for More Convenient Sample Collection and Expanded Viral Transport Media

RARITAN, N.J., April 13, 2021 /CNW/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it received CE Marking for its ...
PR Newswire

Ortho's VITROS® SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data

RARITAN, N.J., March 23, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it received authorization ...